A detailed history of Gm Advisory Group, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Gm Advisory Group, Inc. holds 957 shares of AMGN stock, worth $268,026. This represents 0.02% of its overall portfolio holdings.

Number of Shares
957
Previous 957 -0.0%
Holding current value
$268,026
Previous $299,000 3.01%
% of portfolio
0.02%
Previous 0.02%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$262.75 - $319.31 $5,255 - $6,386
-20 Reduced 2.05%
957 $299,000
Q1 2024

May 09, 2024

BUY
$268.87 - $324.56 $5,377 - $6,491
20 Added 2.09%
977 $277,000
Q3 2023

Nov 13, 2023

SELL
$218.65 - $271.46 $1,093 - $1,357
-5 Reduced 0.52%
957 $257,000
Q2 2023

Aug 14, 2023

SELL
$214.27 - $253.37 $24,855 - $29,390
-116 Reduced 10.76%
962 $213,000
Q1 2023

May 12, 2023

BUY
$225.79 - $275.2 $61,189 - $74,579
271 Added 33.58%
1,078 $260,000
Q4 2022

Feb 13, 2023

BUY
$229.03 - $291.01 $184,827 - $234,845
807 New
807 $211,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $150B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Gm Advisory Group, Inc. Portfolio

Follow Gm Advisory Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gm Advisory Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Gm Advisory Group, Inc. with notifications on news.